H.C. Wainwright maintains Buy rating on Calumet stock, notes strengthened balance sheet

Published 14/01/2025, 13:12
H.C. Wainwright maintains Buy rating on Calumet stock, notes strengthened balance sheet

Tuesday - H.C. Wainwright analysts have maintained a Buy rating on Calumet Specialty Products Partners (NASDAQ: NASDAQ:CLMT) shares.

The upward revision follows the official closure of a $1.44 billion Department of Energy (DoE) loan, which was announced after markets closed on Friday. The loan is anticipated to significantly enhance Calumet's financial position by funding the expansion of the company's renewable fuels production capacity.

The DoE loan is expected to enable Calumet to produce approximately 300 million gallons of Sustainable Aviation Fuel (SAF) and 30 million gallons of Renewable Diesel (RD). In January 2025, Calumet is slated to receive the first tranche of $782 million from the loan.

This initial amount is set to cover costs already incurred by Montana Renewables Limited (MRL) in the expansion efforts. The remaining loan funds will be accessible through a delayed draw construction facility available until 2028, to support the incremental build-out of the MaxSAF project.

In conjunction with the loan's first tranche, Calumet is making a significant $150 million equity investment into MRL from its own balance sheet. The terms of the DoE loan include a 15-year repayment period with an interest rate pegged to the U.S. Treasury Rate plus 3/8%, and the servicing of the principal and interest is deferred until the MaxSAF project is operational.

The analysts at H.C. Wainwright who raised the price target to $33 from $25 cite several factors contributing to the raised price target: a stronger balance sheet, reduced annual debt service costs estimated at $80 million, potential margin enhancements due to a supply-constrained environment for renewable fuels starting in 2025, a cost production advantage over competitors, and the possibility of separating the renewables division from the specialty products business.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.